Vesalio is a privately held medical device company focused on advancing patient care in vascular occlusion by providing physicians with superior technology designed to improve clinical outcomes. Vesalio’s proprietary NeVa™, enVast™ and pVasc™ platforms are designed to effectively remove all types of clot from a patient’s anatomy, leading to complete recanalization of ischemic tissue in the brain, heart and peripheral anatomy, respectively. Vesalio’s NeVa VS™ is a FDA HDE-approved device specifically designed for post-a-SAH vasospasm treatment to effectively dilate critically narrowed vessels.